Study design
vascular calcification
VASCULAR CALCIFICATION
The RenaKvit trial was a 2-year randomised, multicentre, double-blind, placebo-controlled study examining the effects of vitamin K supplementation as menaquinone-7 (MK-7) on bone and vascular calcification in patients on dialysis treatment. The study design and the effects on vascular calcification have been described previously [The study was approved by the Scientific Ethics Committee for the Region of Zealand (SJ-511) and the Danish Data Protection Agency and was registered at ClinicalTrial.gov (NCT02976246). The supporting CONSORT checklist can be found in 